BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 21377506)

  • 21. Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase.
    Lemarteleur T; Gomez D; Paterski R; Mandine E; Mailliet P; Riou JF
    Biochem Biophys Res Commun; 2004 Oct; 323(3):802-8. PubMed ID: 15381071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element.
    Hurley LH; Von Hoff DD; Siddiqui-Jain A; Yang D
    Semin Oncol; 2006 Aug; 33(4):498-512. PubMed ID: 16890804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The c-MYC NHE III(1): function and regulation.
    González V; Hurley LH
    Annu Rev Pharmacol Toxicol; 2010; 50():111-29. PubMed ID: 19922264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico identification of novel ligands for G-quadruplex in the c-MYC promoter.
    Kang HJ; Park HJ
    J Comput Aided Mol Des; 2015 Apr; 29(4):339-48. PubMed ID: 25527072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenanthroline polyazamacrocycles as G-quadruplex DNA binders.
    Carvalho J; Quintela T; Gueddouda NM; Bourdoncle A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
    Org Biomol Chem; 2018 Apr; 16(15):2776-2786. PubMed ID: 29611599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disubstituted 2-phenyl-benzopyranopyrimidine derivatives as a new type of highly selective ligands for telomeric G-quadruplex DNA.
    Wu WB; Chen SH; Hou JQ; Tan JH; Ou TM; Huang SL; Li D; Gu LQ; Huang ZS
    Org Biomol Chem; 2011 Apr; 9(8):2975-86. PubMed ID: 21373680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzothiazole hydrazones of furylbenzamides preferentially stabilize c-MYC and c-KIT1 promoter G-quadruplex DNAs.
    Pany SP; Bommisetti P; Diveshkumar KV; Pradeepkumar PI
    Org Biomol Chem; 2016 Jun; 14(24):5779-93. PubMed ID: 27021281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perylene side chains modulate G-quadruplex conformation in biologically relevant DNA sequences.
    Pivetta C; Lucatello L; Krapcho AP; Gatto B; Palumbo M; Sissi C
    Bioorg Med Chem; 2008 Oct; 16(20):9331-9. PubMed ID: 18819816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinazoline derivative QPB-15e stabilizes the c-myc promoter G-quadruplex and inhibits tumor growth in vivo.
    Li Z; Liu C; Huang C; Meng X; Zhang L; He J; Li J
    Oncotarget; 2016 Jun; 7(23):34266-76. PubMed ID: 27144522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-affinity homologous peptide nucleic acid probes for targeting a quadruplex-forming sequence from a MYC promoter element.
    Roy S; Tanious FA; Wilson WD; Ly DH; Armitage BA
    Biochemistry; 2007 Sep; 46(37):10433-43. PubMed ID: 17718513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectroscopic and biological studies of phenanthroline compounds: selective recognition of gene-promoter G-quadruplex DNAs preferred over duplex DNA.
    Wang L; Wei C
    Chem Biodivers; 2013 Jun; 10(6):1154-64. PubMed ID: 23776031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach.
    Musso L; Mazzini S; Rossini A; Castagnoli L; Scaglioni L; Artali R; Di Nicola M; Zunino F; Dallavalle S
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):615-629. PubMed ID: 29229300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective recognition of oncogene promoter G-quadruplexes by Mg2+.
    Yan YY; Lin J; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
    Biochem Biophys Res Commun; 2010 Nov; 402(4):614-8. PubMed ID: 20971074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
    Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling and biological investigations of an unusual behavior of novel synthesized acridine-based polyamine ligands in the binding of double helix and G-quadruplex DNA.
    Bazzicalupi C; Chioccioli M; Sissi C; Porcù E; Bonaccini C; Pivetta C; Bencini A; Giorgi C; Valtancoli B; Melani F; Gratteri P
    ChemMedChem; 2010 Dec; 5(12):1995-2005. PubMed ID: 20957717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inducement of G-quadruplex DNA forming and down-regulation of oncogene c-myc by bile acid-amino acid conjugate-BAA.
    Tian M; Zhang X; Li Y; Ju Y; Xiang J; Zhao C; Tang Y
    Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):190-9. PubMed ID: 20408050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
    Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
    J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic resolution of bimolecular hybridization versus intramolecular folding in nucleic acids by surface plasmon resonance: application to G-quadruplex/duplex competition in human c-myc promoter.
    Halder K; Chowdhury S
    Nucleic Acids Res; 2005; 33(14):4466-74. PubMed ID: 16085756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel interaction of the Z-DNA binding domain of human ADAR1 with the oncogenic c-Myc promoter G-quadruplex.
    Kang HJ; Le TV; Kim K; Hur J; Kim KK; Park HJ
    J Mol Biol; 2014 Jul; 426(14):2594-604. PubMed ID: 24813121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topology specific stabilization of promoter over telomeric G-quadruplex DNAs by bisbenzimidazole carboxamide derivatives.
    Dhamodharan V; Harikrishna S; Bhasikuttan AC; Pradeepkumar PI
    ACS Chem Biol; 2015 Mar; 10(3):821-33. PubMed ID: 25495750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.